<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
MEdia Clips

CU Anschutz In The News

By Media Outlet

Cure Today

Cure Today

‘Pivotal’ Time for DLBCL Treatment Options

news outletCure Today
Publish DateSeptember 08, 2023

“I do believe things are looking really good for patients with DLBCL,” Dr. Manali Kamdar, a clinical researcher in the field of blood cancers at the University of Colorado Anschutz Medical Campus, tells us. Kamdar describes 2022 and 2023 as “pivotal in terms of having more medications approved for patients with large-cell lymphoma.”

Full Story